🇺🇸 FDA
Patent

US 8124653

Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia

granted A61KA61K31/505A61K9/0097

Quick answer

US patent 8124653 (Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia) held by The Board of Regents of the University of Texas System expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/505, A61K9/0097, A61P, A61P25/00